Carlyle Group Sells 4.3% Stake in Indegene for Rs 636 Crore in Open Market Transaction

Global investment firm Carlyle Group has reduced its stake in the healthcare technology company Indegene. Through its affiliate, CA Dawn Investments, Carlyle sold a 4.3% stake, equivalent to 1,02,63,785 shares, for Rs 636 crore via an open market transaction. The shares were sold at an average price of Rs 619.82 each. This sale decreased Carlyle's holding in Indegene from 14.52% to 10.22%.

Representative image

Capital Group's Stake Reduction

In a separate development, Capital Group reduced its stake in Medi Assist Healthcare Services. Through SmallCap World Fund Inc, it sold a 2.24% stake, or 15.75 lakh shares, for nearly Rs 93 crore on both the NSE and BSE. The shares were sold at an average price of Rs 588 each, bringing the total transaction value to Rs 92.65 crore.

Following this transaction, Capital Group's shareholding in Medi Assist Healthcare Services decreased from 2.93% to 0.7%. The identities of the buyers for both Indegene and Medi Assist Healthcare Services remain undisclosed on the exchanges.

Market Reactions

Indegene's share price fell by 6.06%, closing at Rs 627 on the NSE after Carlyle's divestment. Meanwhile, Medi Assist Healthcare Services saw a slight increase of 0.18% on the BSE, closing at Rs 588.20 per share. On the NSE, however, it closed slightly lower at Rs 586.20 per share.

These transactions highlight ongoing adjustments in investment portfolios by major financial entities like Carlyle Group and Capital Group within India's healthcare sector.